Ocular surface complications of local anticancer drugs for treatment of ocular tumors

Jayoon Moon, Se Hyun Choi, Min Joung Lee, Dong Hyun Jo, Un Chul Park, Sun Ok Yoon, Se Joon Woo, Joo Youn Oh

Research output: Contribution to journalReview articlepeer-review


Local chemotherapy is increasingly used, either in combination with surgery or as monotherapy, for management of ocular tumors. Yet many of the local chemotherapeutic agents used for ocular tumors are cytotoxic drugs that are frequently associated with toxicities in normal ocular tissues. Understanding and managing these side effects are important because they affect treatment tolerability, outcome and quality of vision. Herein, we review local anticancer drugs administered for the treatment of ocular tumors, with an emphasis on their toxicities to the ocular surface, adnexa and lacrimal drainage system. We provide the underlying mechanisms and management strategies for the ocular side effects. Recent innovations in anticancer immunotherapy and ocular drug delivery systems also are discussed as new potential therapeutic modalities for alleviation of side effects.

Original languageEnglish
Pages (from-to)16-30
Number of pages15
JournalOcular Surface
StatePublished - Jan 2021


  • Anticancer drug
  • Complication
  • Efficacy
  • Local chemotherapy
  • Ocular surface
  • Ocular tumor
  • Side effect
  • Toxicity

Fingerprint Dive into the research topics of 'Ocular surface complications of local anticancer drugs for treatment of ocular tumors'. Together they form a unique fingerprint.

Cite this